+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Home Healthcare Market Report by Component, Indication, States and Company Analysis, 2025-2033

  • PDF Icon

    Report

  • 200 Pages
  • September 2025
  • Region: United States
  • Renub Research
  • ID: 6178776
The United States Home Healthcare Market is expected to see substantial growth, rising from US$ 115.13 Billion in 2024 to US$ 210.25 Billion in 2033. This growth reflects a strong Compound Annual Growth Rate (CAGR) of 6.92% from 2025 to 2033. The drivers of this growth are an aging population, a higher incidence of chronic diseases, and a preference for in-home care services, which promote patient comfort and convenience.

United States Home Healthcare Market Size

Home healthcare is a set of medical and non-medical services provided in the home environment of a patient to enhance health and wellbeing. The services may involve nursing services, physical therapy, occupational therapy, and daily living assistance like bathing, dressing, and food preparation. Home healthcare seeks to deliver individualized care in accordance with unique needs, enabling patients to stay at home while receiving required medical care.

Home healthcare has gained immense popularity in recent years in the United States for a number of reasons. The boom generation that is aging is now looking for alternatives to hospitalization and wants the convenience of recovery and management of chronic diseases in the comfort of home. Further, technology has allowed medical professionals to provide effective and efficient care from a distance, making the service more accessible.

Insurance providers have also come to appreciate the worth of home healthcare, tending to cover a wider array of services, further increasing its popularity. Therefore, home healthcare is becoming an essential part of the American healthcare system, providing affordable solutions prioritizing patient convenience and health.

Growth Drivers in the United States Home Healthcare Market

Aging Population and Increasing Chronic Diseases

The United States has a rapidly growing population of the elderly, with millions of people aged above 65 needing constant medical care. This age pattern is among the most powerful forces behind the home healthcare market. Older people tend to have chronic conditions like cardiovascular disease, diabetes, arthritis, and respiratory ailments, which need long-term treatment and observation. Home healthcare is a cost-effective, comfortable, and personalized option compared to hospitalization or long-term care institutions. The number of Americans aged 65 and older will grow from 58 million in 2022 to 82 million in 2050 (a 47% increase), and the 65-and-older segment's proportion of the entire population is expected to increase from 17% to 23%.

Cost-Effectiveness Compared to Institutional Care

The increasing hospital and nursing facility costs are driving patients and healthcare systems alike to look toward home healthcare as a viable option. Home healthcare services, including skilled nursing, physio, wound care, and chronic disease management, can be provided at a fifth of the price of inpatient care. This is especially significant in the U.S., where healthcare costs are among the highest in the world. Home healthcare usage is promoted by insurance companies and government programs more and more to eliminate the cost burden on the healthcare system. For patients, home-based care eliminates costs of prolonged hospitalization, transportation, and ancillary services.

Technological Advances in Remote Care

Advancements in healthcare technology have revolutionized the business of home healthcare in the United States. The convergence of telehealth platforms, wearable monitoring devices, mobile applications, and artificial intelligence-enabled diagnostic solutions enables healthcare professionals to provide quality care remotely. Patients with conditions such as heart failure, diabetes, or COPD can now be continuously monitored in real time without multiple hospital visits. All this enhances drug compliance, increases patient safety, and prevents hospital readmissions. Technology also facilitates caregivers to identify early warning signs and act in a timely manner, enhancing patient outcomes. U.S. Food and Drug Administration is issuing the launch of a new initiative, Home as a Health Care Hub, to assist in reimagining the home setting as a central part of the health care system, with the aim of driving forward health and wellness for everyone in the U.S. Although most care options are presently trying to utilize the home as a virtual clinical location, few have contemplated the structural and critical aspects of the home that will be needed to accommodate this transference of care.

Challenges in the United States Home Healthcare Market

Workforce Shortages and Training Gaps

One of the biggest challenges the U.S. home healthcare market confronts is the lack of capable health-care practitioners. With demand increasing fast for home care, great pressure is placed on the workforce, such as nurses, therapists, and home health aides. Numerous professionals are being overloaded, and as a result, burnout and high turnover occur. Also, training deficits are present, especially in managing sophisticated technologies and multiple complex chronic conditions in the home environment. The absence of standardized training and certification programs makes service quality even more difficult. For patients, this workforce stress can lead to variable delivery of care and extended wait times for services. The solution to this entails investment in workforce development, improved wages, and career advancement opportunities to recruit and retain the best talent.

Regulatory and Reimbursement Complexities

The U.S. home healthcare market is confronted by complicated regulatory environments and reimbursement issues that interfere with seamless market expansion. Home care services are regulated by strict state and federal regulations, making differences in compliance needs across states. Administrative tasks of licensing, quality reporting, and documentation frequently burden providers. Reimbursement concerns bring an added layer of complexity, as Medicare, Medicaid, and private insurance coverage differ markedly. Certain vital services and sophisticated technologies are poorly reimbursed, making them unaffordable and inaccessible for patients. Smaller providers especially face financial unsustainability under such circumstances. Reimbursement delays also impact cash flow, which poses operational challenges.

United States Home Healthcare Services Market

Home healthcare services comprise the majority of the U.S. home healthcare market and encompass a broad range of services including skilled nursing, physical therapy, occupational therapy, speech therapy, and personal care aid. These services are highly sought as chronic diseases continue to grow in prevalence and people increasingly seek to age in place. Patients gain the advantage of expert medical care without the anxiety of having to be hospitalized, and families are pleased with the cost-effectiveness and convenience of home care. Home-based skilled nursing care is especially crucial for post-surgical patients and patients dealing with chronic diseases. Additionally, growth in home-based rehabilitation service has decreased reliance on outpatient clinics.

United States Home Healthcare Equipment Market

The U.S. home healthcare market equipment segment entails a wide variety of products including infusion pumps, blood glucose monitors, respiratory devices, remote monitoring systems, and mobility aids. Demand for medical equipment for home use is growing as patients want to be independent and have convenience when it comes to managing chronic diseases. The technological breakthroughs, including portable oxygen concentrators, intelligent insulin pumps, and connected devices, are revolutionizing the patient experience through real-time monitoring and better outcomes. The COVID-19 pandemic situation emphasized the need for medical devices to be accessible for home use, driving consumer adoption. Moreover, insurance coverage for durable medical equipment has increased access for most patients.

United States Cancer Home Healthcare Market

Cancer patients usually need prolonged care, symptom control, and emotional support, which makes home healthcare a more sought-after option. In the United States, cancer home healthcare encompasses services such as pain control, chemotherapy delivery, nutritional management, and counseling of the psyche. Patients enjoy fewer hospital visits, decreased risk of infection, and the comfort of familiar environment while undergoing treatment. It is also valued by family members for the opportunity to care without the hassles of constant hospital commuting. Home healthcare workers employ sophisticated medical equipment and telehealth technology to track patients' progress so that interventions can be made at the right time. Cancer is among the top causes of morbidity in the U.S., with high growth in demand for specialized home-based oncology services.

United States Diabetes & Kidney Disorders Home Healthcare Market

Diabetes and kidney disease account for a major share of the U.S. home healthcare market, with the high incidence of these diseases. Home treatment for diabetes involves glucose testing, insulin therapy, diet control, and patient training. In the case of kidney disease, services can include support in dialysis, medication control, and ongoing monitoring of patient health parameters. The availability of wearable devices, including continuous glucose monitors (CGMs), has enhanced the management of diabetes at home as well as convenience. Patients enjoy real-time tracking of data and decreased reliance on hospitalization. In a similar way, portable dialysis machines and supportive care have improved the quality of life for patients of kidney disorders.

United States Respiratory Disease & COPD Home Healthcare Market

Respiratory illnesses, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, are among the top drivers of home healthcare demand within the U.S. Individuals suffering from these conditions are likely to need extended respiratory care and monitoring, which can best be provided in the home setting. Home respiratory care usually involves oxygen therapy, nebulizer sessions, ventilator assistance, and pulmonary rehabilitation therapy. Portable oxygen concentrators and intelligent inhalers have transformed home care, enhancing patient mobility and autonomy. Since COPD is the primary reason for hospital admission, home care has significantly decreased the rate of hospital readmission, lowering both patient and healthcare system expenditure.

California Home Healthcare Market

California boasts one of the most advanced home healthcare markets in the United States through its high population, aging population, and robust healthcare infrastructure. Urban areas such as San Francisco and Los Angeles drive demand for home healthcare services, with a dense population of providers and patients. The state's emphasis on innovative healthcare service delivery, such as telehealth and digital monitoring devices, has driven adoption of care in the home. California also boasts a diverse population, driving demand for tailored care methods among diverse cultural and socioeconomic segments. The fact that numerous top-tier home healthcare agencies and tech start-ups abound in the area also enhances market competition.

New York Home Healthcare Market

New York is yet another central hub for the U.S. home healthcare market with robust demand fueled by its heavily populated urban cities and prevalence of chronic ailments. The state boasts a highly developed network of home healthcare agencies providing a variety of services from skilled nursing to rehab and personal care. In urban centers such as New York City, there is especially strong demand because of the expense of hospital stays and the ease of having care at home for patients. The state also possesses one of the largest populations aged, further adding to market potential. Government-sponsored programs and Medicaid funding also play a vital part in enabling home healthcare accessibility throughout New York. Technological innovation, such as telehealth solutions, has grown considerably within the state, enabling providers to treat patients more effectively. Due to its high healthcare demand and diverse population, New York remains a key home healthcare market.

Washington Home Healthcare Market

Washington state is becoming an emerging home healthcare market due to its advanced healthcare laws and patient-centric culture. Such cities as Seattle possess a rich culture of embracing new health solutions, and as such, the state provides a perfect setting for the extension of home-based care services. The state possesses a comparatively large aging population, and many prevalent illnesses are chronic diseases like diabetes, respiratory conditions, and cardiovascular illnesses, all of which establish high demand for home healthcare. The state also promotes the utilization of telehealth and online devices in increasing accessibility among patients from urban and rural backgrounds. Washington healthcare providers tend to concentrate on comprehensive care models, integrating professional medical services with support and education for patients.

Market Segmentations

Component

  • Services
  • Equipment

Indication

  • Neurological & Mental Disorders
  • Diabetes & Kidney Disorders
  • Cancer
  • Respiratory Disease & COPD
  • Mobility Disorders
  • Cardiovascular Disorder & Hypertension
  • Wound Care
  • Maternal Disorders
  • Others

Top States

  • California
  • Texas
  • New York
  • Florida
  • Illinois
  • Pennsylvania
  • Ohio
  • Georgia
  • New Jersey
  • Washington
  • North Carolina
  • Massachusetts
  • Virginia
  • Michigan
  • Maryland
  • Colorado
  • Tennessee
  • Indiana
  • Arizona
  • Minnesota
  • Wisconsin
  • Missouri
  • Connecticut
  • South Carolina
  • Oregon
  • Louisiana
  • Alabama
  • Kentucky
  • Rest of United States

All companies have been covered with 5 Viewpoints

  • Overviews
  • Key Persons
  • Recent Developments
  • SWOT Analysis
  • Revenue Analysis

Company Analysis:

  • 3M Healthcare
  • Apple Inc.
  • Arkray, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson And Company
  • F. Hoffmann-La Roche AG
  • Fresenius SE & Co KGaA
  • Hollister Inc.

Table of Contents

1. Introduction
2. Research & Methodology
2.1 Data Source
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Research Approach
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Forecast Projection Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. United States Home Healthcare Market
5.1 Historical Market Trends
5.2 Market Forecast
6. Market Share Analysis
6.1 By Component
6.2 By Indication
6.3 By States
7. Component
7.1 Services
7.1.1 Market Analysis
7.1.2 Market Size & Forecast
7.2 Equipment
7.2.1 Market Analysis
7.2.2 Market Size & Forecast
8. Indication
8.1 Neurological & Mental Disorders
8.1.1 Market Analysis
8.1.2 Market Size & Forecast
8.2 Diabetes & Kidney Disorders
8.2.1 Market Analysis
8.2.2 Market Size & Forecast
8.3 Cancer
8.3.1 Market Analysis
8.3.2 Market Size & Forecast
8.4 Respiratory Disease & COPD
8.4.1 Market Analysis
8.4.2 Market Size & Forecast
8.5 Mobility Disorders
8.5.1 Market Analysis
8.5.2 Market Size & Forecast
8.6 Cardiovascular Disorder & Hypertension
8.6.1 Market Analysis
8.6.2 Market Size & Forecast
8.7 Wound Care
8.7.1 Market Analysis
8.7.2 Market Size & Forecast
8.8 Maternal Disorders
8.8.1 Market Analysis
8.8.2 Market Size & Forecast
8.9 Others
8.9.1 Market Analysis
8.9.2 Market Size & Forecast
9. Top States
9.1 California
9.1.1 Market Analysis
9.1.2 Market Size & Forecast
9.2 Texas
9.2.1 Market Analysis
9.2.2 Market Size & Forecast
9.3 New York
9.3.1 Market Analysis
9.3.2 Market Size & Forecast
9.4 Florida
9.4.1 Market Analysis
9.4.2 Market Size & Forecast
9.5 Illinois
9.5.1 Market Analysis
9.5.2 Market Size & Forecast
9.6 Pennsylvania
9.6.1 Market Analysis
9.6.2 Market Size & Forecast
9.7 Ohio
9.7.1 Market Analysis
9.7.2 Market Size & Forecast
9.8 Georgia
9.8.1 Market Analysis
9.8.2 Market Size & Forecast
9.9 New Jersey
9.9.1 Market Analysis
9.9.2 Market Size & Forecast
9.10 Washington
9.10.1 Market Analysis
9.10.2 Market Size & Forecast
9.11 North Carolina
9.11.1 Market Analysis
9.11.2 Market Size & Forecast
9.12 Massachusetts
9.12.1 Market Analysis
9.12.2 Market Size & Forecast
9.13 Virginia
9.13.1 Market Analysis
9.13.2 Market Size & Forecast
9.14 Michigan
9.14.1 Market Analysis
9.14.2 Market Size & Forecast
9.15 Maryland
9.15.1 Market Analysis
9.15.2 Market Size & Forecast
9.16 Colorado
9.16.1 Market Analysis
9.16.2 Market Size & Forecast
9.17 Tennessee
9.17.1 Market Analysis
9.17.2 Market Size & Forecast
9.18 Indiana
9.18.1 Market Analysis
9.18.2 Market Size & Forecast
9.19 Arizona
9.19.1 Market Analysis
9.19.2 Market Size & Forecast
9.20 Minnesota
9.20.1 Market Analysis
9.20.2 Market Size & Forecast
9.21 Wisconsin
9.21.1 Market Analysis
9.21.2 Market Size & Forecast
9.22 Missouri
9.22.1 Market Analysis
9.22.2 Market Size & Forecast
9.23 Connecticut
9.23.1 Market Analysis
9.23.2 Market Size & Forecast
9.24 South Carolina
9.24.1 Market Analysis
9.24.2 Market Size & Forecast
9.25 Oregon
9.25.1 Market Analysis
9.25.2 Market Size & Forecast
9.26 Louisiana
9.26.1 Market Analysis
9.26.2 Market Size & Forecast
9.27 Alabama
9.27.1 Market Analysis
9.27.2 Market Size & Forecast
9.28 Kentucky
9.28.1 Market Analysis
9.28.2 Market Size & Forecast
9.29 Rest of United States
9.29.1 Market Analysis
9.29.2 Market Size & Forecast
10. Value Chain Analysis
11. Porter's Five Forces Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Competition
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threats
13. Pricing Benchmark Analysis
13.1 3M Healthcare
13.2 Apple Inc.
13.3 Arkray, Inc.
13.4 B. Braun Melsungen AG
13.5 Becton, Dickinson And Company
13.6 F. Hoffmann-La Roche AG
13.7 Fresenius SE & Co KGaA
13.8 Hollister Inc.
14. Key Players Analysis
14.1 3M Healthcare
14.1.1 Overviews
14.1.2 Key Persons
14.1.3 Recent Developments
14.1.4 SWOT Analysis
14.1.5 Revenue Analysis
14.2 Apple Inc.
14.2.1 Overviews
14.2.2 Key Persons
14.2.3 Recent Developments
14.2.4 SWOT Analysis
14.2.5 Revenue Analysis
14.3 Arkray, Inc.
14.3.1 Overviews
14.3.2 Key Persons
14.3.3 Recent Developments
14.3.4 SWOT Analysis
14.3.5 Revenue Analysis
14.4 B. Braun Melsungen AG
14.4.1 Overviews
14.4.2 Key Persons
14.4.3 Recent Developments
14.4.4 SWOT Analysis
14.4.5 Revenue Analysis
14.5 Becton, Dickinson And Company
14.5.1 Overviews
14.5.2 Key Persons
14.5.3 Recent Developments
14.5.4 SWOT Analysis
14.5.5 Revenue Analysis
14.6 F. Hoffmann-La Roche AG
14.6.1 Overviews
14.6.2 Key Persons
14.6.3 Recent Developments
14.6.4 SWOT Analysis
14.6.5 Revenue Analysis
14.7 Fresenius SE & Co KGaA
14.7.1 Overviews
14.7.2 Key Persons
14.7.3 Recent Developments
14.7.4 SWOT Analysis
14.7.5 Revenue Analysis
14.8 Hollister Inc.
14.8.1 Overviews
14.8.2 Key Persons
14.8.3 Recent Developments
14.8.4 SWOT Analysis
14.8.5 Revenue Analysis

Companies Mentioned

  • 3M Healthcare
  • Apple Inc.
  • Arkray, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson And Company
  • F. Hoffmann-La Roche AG
  • Fresenius SE & Co KGaA
  • Hollister Inc.

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information